Emanuele C. Mingo
Rome, 00128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Skeletal metastatic burden as a strong prognostic factor of survival in advanced NSCLC treated with chemo-immunotherapy: An exploratory imaging-based analysis.
Journal: Journal of bone oncology
Published: June 18, 2026
Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 18, 2026
Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer.
Journal: Journal of translational medicine
Published: October 17, 2025
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis.
Journal: Cancers
Published: May 15, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Journal: Nature communications
Published: May 11, 2025
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.
Journal: NPJ precision oncology
Published: April 03, 2025
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature Review.
Journal: Clinical lung cancer
Published: March 10, 2025
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.
Journal: Journal of chemotherapy (Florence, Italy)
Published: August 06, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026